Q1. What is global regulatory strategy development?
Developing a global regulatory strategy involves planning to obtain a medicine’s approval across multiple markets. It spans coordination of submission timing, evidence generation, and lifecycle planning.
Q2. When should regulatory strategy begin?
It should begin early, ideally before key nonclinical work, so development decisions support the target markets from the start.
Q3. Why is CMC important?
Because manufacturing quality, stability, and control data are central to approval and to post-approval changes.
Q. How does Pharmacovigilance (PV) fit into developing a global regulatory strategy?
Pharmacovigilance ensures that safety monitoring is planned from development through post-marketing, supporting compliance and risk management.
Q1. Is the same regulatory strategy used for biologics and small molecules?
No. The core framework is similar, but biologics often need additional manufacturing and comparability planning.
Comments are closed